MITOMYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mitomycin, and when can generic versions of Mitomycin launch?
Mitomycin is a drug marketed by Accord Hlthcare, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Meitheal, and Rk Pharma. and is included in twelve NDAs.
The generic ingredient in MITOMYCIN is mitomycin. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mitomycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mitomycin
A generic version of MITOMYCIN was approved as mitomycin by HIKMA on April 19th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MITOMYCIN?
- What are the global sales for MITOMYCIN?
- What is Average Wholesale Price for MITOMYCIN?
Summary for MITOMYCIN
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 240 |
| Patent Applications: | 4,409 |
| Drug Prices: | Drug price information for MITOMYCIN |
| DailyMed Link: | MITOMYCIN at DailyMed |
Recent Clinical Trials for MITOMYCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| City of Hope Medical Center | Phase 2 |
| Columbia University | N/A |
| Varian | N/A |
Pharmacology for MITOMYCIN
| Drug Class | Alkylating Drug |
| Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for MITOMYCIN
Anatomical Therapeutic Chemical (ATC) Classes for MITOMYCIN
US Patents and Regulatory Information for MITOMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 064144-001 | Apr 30, 1998 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 064106-001 | Nov 29, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rk Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 203386-001 | Oct 13, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 211269-001 | Apr 5, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 216732-001 | Oct 30, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland Pharma Ltd | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 216648-001 | Nov 22, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meitheal | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 214505-002 | Sep 8, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
